Form 4: Rapport Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Abraham Ceesay, Chief Executive Officer and a Director of Rapport Therapeutics, Inc., sold 51,499 shares of common stock on August 10, 2026.
Summary
- Open-market sale: disposed of 14,171 Common Stock at $45.97 ($651,492) on August 10, 2026; holds 523,436 after (Direct).
- Open-market sale: disposed of 8,370 Common Stock at $46.75 ($391,280) on August 10, 2026; holds 515,066 after (Direct).
- Open-market sale: disposed of 3,664 Common Stock at $46.90 ($171,837) on August 11, 2026; holds 511,402 after (Direct).
- Open-market sale: disposed of 19,500 Common Stock at $48.04 ($936,846) on August 11, 2026; holds 491,902 after (Direct).
- Open-market sale: disposed of 5,794 Common Stock at $48.62 ($281,721) on August 11, 2026; holds 486,108 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,433,176 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Abraham Ceesay — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Open-market sale | Common Stock | 14,171 | $46 | $651.5K | 523,436 |
| 2026-08-10 | Open-market sale | Common Stock | 8,370 | $47 | $391.3K | 515,066 |
| 2026-08-11 | Open-market sale | Common Stock | 3,664 | $47 | $171.8K | 511,402 |
| 2026-08-11 | Open-market sale | Common Stock | 19,500 | $48 | $936.8K | 491,902 |
| 2026-08-11 | Open-market sale | Common Stock | 5,794 | $49 | $281.7K | 486,108 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Open-market sale (14,171 shares) |
| 2026-08-10 | Open-market sale (8,370 shares) |
| 2026-08-11 | Open-market sale (3,664 shares) |
| 2026-08-11 | Open-market sale (19,500 shares) |
| 2026-08-11 | Open-market sale (5,794 shares) |
Keywords
insider transaction, Form 4, RAPP, Rapport Therapeutics, Inc., bearish, Abraham Ceesay
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.